Format

Send to

Choose Destination
Iran J Basic Med Sci. 2017 Jun;20(6):604-612. doi: 10.22038/IJBMS.2017.8827.

Bio-effectiveness of the main flavonoids of Achillea millefolium in the pathophysiology of neurodegenerative disorders- a review.

Author information

1
Physiology-Pharmacology Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
2
Department of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
3
Geriatric Care Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
4
Department of Neurology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
5
Pistachio Safety Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
6
Non-communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Abstract

The Achillea millefolium L. (Yarrow) is a common herb which is widely being used, worldwide. Achillea is being used for treatment of many disorders since centuries. It is considered safe for supplemental use and flavonoids such as kaempferol, luteolin and apigenin are of main constituents present in Achillea. Most of both antioxidant and anti-inflammatory properties of this herb have been attributed to its flavonoid content. Oxidative and inflammatory processes play important roles in pathogenesis of neurodegenerative diseases. Present review was aimed to review the latest literature evidences regarding application of Achillea and/or its three main flavonoid constituents on epilepsy, Alzheimer's disease, multiple sclerosis, Parkinson's disease and stroke.

KEYWORDS:

Achillea millefolium; Flavonoids; Medicinal; Neurodegenerative – disease; Plants

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center